The Australasian Society of Clinical Immunology and Allergy (ASCIA) was established in 1990 as the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA is a Company limited by guarantee (ACN 608 798 241; ABN 45 615 521 452) and is registered with the Australian Charities and Not-for-profits Commission (ACNC) https://www.acnc.gov.au/charity/e79f36de081f49213f96361b173c5d91
ASCIA is a member society of the World Allergy Organisation (WAO) and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). ASCIA is also affiliated with the Royal Australasian College of Physicians (RACP) as a specialty society.
- Mission and Objectives
- COVID-19 Safety Plan
- Code of Conduct
- Committees and working parties
- Conferences and Meetings
Advance the science and practice of allergy and clinical immunology, by promoting the highest standard of medical practice, training, education and research, to improve the health and quality of life of people with immune system disorders. These include allergic diseases, immunodeficiencies and other immune diseases.
- Standards - Promote the highest standards of allergy and immunology medical training, practice and care. ASCIA achieves this objective through providing accessible, consistent and evidence-based education and resources that are used throughout Australia and New Zealand to assist in the prevention, diagnosis, management and treatment of allergy, anaphylaxis, immunodeficiencies and other immune diseases.
- Education and Training- Provide high quality allergy and immunology education for ASCIA members, other health professionals, patients, consumers and carers. ASCIA achieves this objective through hosting the ASCIA Annual Conference, ASCIA e-training courses and providing information for health professionals, patients, carers and consumers, which is regularly reviewed, updated and augmented.
- Expertise and Advice - Utilise ASCIA and stakeholder expertise to address allergy and immunology issues, provide advice, representation and submissions to government and other organisations. ASCIA achieves this objective by making submissions and responding to government and other organisations.
- Advocacy and Collaborations - Increase the profile of allergy, immunology and immunopathology and advocate for patients. ASCIA has been working on advocacy for the past 30 years and is involved in many collaborations.
- Research - Promote and fund research to improve health and quality of life of people with allergy and other immune diseases. ASCIA achieves this through AIFA, the Allergy and Immunology Foundation of Australasia, which was established by ASCIA in 2013, to fund research into allergy, immunodeficiency and other immune diseases. . www.allergyimmunology.org.au
For details about ASCIA initiatives and priorities go to www.allergy.org.au/about-ascia/ascia-initiatives
This ASCIA COVID-19 Office Safety Plan provides the framework through which ASCIA responds to the COVID-19 pandemic as an ongoing public health issue. This requires multiple actions to:
ASCIA relies on the highly valued work from employees, contractors and the voluntary contributions of ASCIA members. In the course of doing this work, ASCIA is committed to ensuring that all ASCIA employees, contractors and members behave towards each other with fairness, dignity, courtesy and respect, without bullying, harassment or discrimination. Inappropriate behaviour that is regarded as bullying, harassment or discrimination of ASCIA employees, contractors and members (involved in ASCIA, AIFA or National Allergy Strategy activities) should be reported to the ASCIA CEO and/or the ASCIA President, as outlined in the ASCIA Code of Conduct (effective as of 1st November 2019).
The ASCIA Code of Conduct has been adapted from the Royal Australasian College of Physicians (RACP) "Working Together" policy, which outlines the expected code of conduct to support fair treatment for all, without bullying, harassment or discrimination.
ASCIA members are health professionals who work in the areas of allergy, clinical immunology and immunopathology. As of December 2020, there are 677 ASCIA members, comprising:
- 268 Full ASCIA members, who are mainly clinical immunology/allergy specialists and they are listed on the ASCIA website www.allergy.org.au/patients/locate-a-specialist
- 58 Associate (Trainee) members, who are completing their advanced training to become clinical immunology/allergy specialists.
- 130 Associate (Medical) members, who are medical practitioners with an interest in allergy, but are not clinical immunology/allergy specialists.
- 166 Associate (Other Health Professional) members, including 113 nurses and 44 dietitians.
- 36 Associate (Scientist/Researcher) members.
- 19 Retired ASCIA members.
All current ASCIA members are listed on www.allergy.org.au/members/directory (members section of the ASCIA website).
Membership applications are available from the ASCIA website www.allergy.org.au/members/apply
ASCIA members diagnose, treat and manage patients with allergies, immunodeficiencies and other immune diseases:
- Allergic diseases are amongst the fastest growing chronic disease and public health issues in Australia and New Zealand, affecting around 20% of the population. They include food, insect and drug allergies, asthma, allergic rhinitis (hay fever) and eczema. Allergic diseases, particularly food allergy and drug allergy, are increasing in prevalence, complexity and severity. The most severe type of allergic reaction is known as anaphylaxis, which is potentially life threatening.
- Immunodeficiency diseases are serious, potentially life threatening conditions that are increasing in number and complexity. Delay in diagnosis of immunodeficiency disease leads to poor health outcomes and premature death.
- There are more than 100 different autoimmune diseases that affect around 5% of the population and if not appropriately managed, these can lead to significant disability.
For details about ASCIA initiatives and prioritiies go to www.allergy.org.au/about-ascia/ascia-initiatives
The following ASCIA committees are standing committees of the ASCIA Council, with representation on Council:
- ASCIA Anaphylaxis committee
- ASCIA Drug Allergy committee
- ASCIA Education committee
- ASCIA Immunodeficiency committee
- ASCIA Laboratory Practice committee
- ASCIA Paediatric committee
- ASCIA Nurses committee
- ASCIA Dietitians committee
In addition to the above mentioned committees there are ASCIA working parties and interest groups, which are not standing committees of the ASCIA Council.
Further information is available at www.allergy.org.au/members/committees
For qualifications of members go to www.allergy.org.au/patients/locate-a-specialist
ASCIA educational activities include:
Health professional programs (e.g. ASCIA Annual Conferences, advanced training meetings, e-training courses, clinical updates, guidelines, position/consensus statements, action plans, treatment/management plans, checklists, anaphylaxis resources, registers).
Public education programs (e.g. ASCIA information for patients, consumers and carers, anaphylaxis resources, e-training courses for schools, childcare services and e-training courses for the community.
ASCIA educational activities are dependent on:
Funding derived from membership fees, educational grants from governments for specific projects and unrestricted educational grants from industry.
ASCIA members providing their expertise and time pro-bono.
For more details about sponsors and the ASCIA sponsorship policy go to www.allergy.org.au/about-ascia/sponsors
ASCIA Annual Conferences are usually held in September, with locations rotating between Australian states and New Zealand on approximately a six year cycle. Further information is available at www.allergy.org.au/conferences/ascia-annual-conference
In addition there are more regular educational meetings for ASCIA members which are organised by local ASCIA area representatives. Sponsorship of these meetings is not included in the ASCIA sponsorship categories listed above, as they are regional specific events.
ASCIA Update is a free e-newsletter that provides current news to the community about new or updated resources and other relevant information about allergy and other immune diseases. You can subscribe by simply entering your name and email address in the section under ASCIA Update on the right hand side of the ASCIA website homepage www.allergy.org.au
Subscriber details remain confidential. To review our privacy information go to www.allergy.org.au/about-ascia/disclaimer-and-privacy#privacy
If you no longer wish to receive the ASCIA Update e-newsletter you can unsubscribe at any time.
Previous issues are available open access at www.allergy.org.au/about-ascia/updates
ASCIA members receive a monthy e-newletter as part of their membership entitlements, which includes information similar to the ASCIA Update newsletter, in addtion to mmeber specific information.
Content updated February 2021